HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study Academic Article uri icon

Overview

MeSH Major

  • Biomarkers, Tumor
  • Bone Neoplasms
  • Osteosarcoma
  • Receptor, ErbB-2

abstract

  • HER-2 expression is not prognostic in osteosarcoma in the context of this large prospective study. HER-2 expression cannot be used as a basis for stratification of therapy. Identification of potential prognostic factors should occur in the context of large multi-institutional biology studies.

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4288578

Digital Object Identifier (DOI)

  • 10.1002/pbc.25074

PubMed ID

  • 24753182

Additional Document Info

start page

  • 1558

end page

  • 64

volume

  • 61

number

  • 9